MEaDvise

MEaDvise improves pre-diabetic and diabetic patients’ outcomes and reduces the cost for insurers and individuals through personalized risk identification, care coordination, and digital health intervention.   MEaDvise Team: Abbas Shojaee

Read More

ELIV5

ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.   ELIV5 Team: Choukri Ben…

Read More

Yiviva

Yiviva is a biotechnology company developing high-quality, evidence-based, botanical products to address aging-associated diseases. Yiviva Team: Peikwen Cheng Shwu-Huey Liu

Read More

Cytosolix

Cytosolix is developing a small-molecule tumor targeted chemotherapy platform.   Cytosolix Team: John C. Deacon, Ph.D., Founder and President

Read More